Insider Transactions Reported by 21 Insiders of Niagen Bioscience, Inc.

Symbol
NAGE on Nasdaq
Location
Los Angeles, CA

Insiders trading volume in the past year

Niagen Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chau Hoi Shuen Solina Holly 10%+ Owner $27.2M 30 Sep 2022
Champion River Ventures Ltd Director, 10%+ Owner $16.1M 06 Sep 2023
Frank L. Jaksch Jr Director $14.4M 24 Jun 2025
Robert N. Fried Chief Executive Officer, Director $5.43M 09 Apr 2025
Ozan Pamir Chief Financial Officer $65.4K +$45.6K +230% 14 Nov 2025
Brianna Gerber Chief Financial Officer $40.4K 22 Feb 2024
Carlos Luis Lopez SVP, General Counsel $17.7K +$2.15K +13.8% 07 Mar 2025
Li Ka Shing 10%+ Owner $0 06 Sep 2023
Kristin Patrick Director $0 24 Jun 2025
Jeong James Lee Interim CFO 16 Jul 2024
KURT A. GUSTAFSON Director 17 Jun 2021
Tsz Ho Tony LAU Director 17 Jun 2021
Jeff Baxter Director 17 Jun 2021
STEPHEN A. BLOCK Director 17 Jun 2021
KEVIN M. FARR Chief Financial Officer 12 Aug 2022
Caroline S. Levy Director 01 Dec 2021
Ann Cohen Director 24 Jun 2025
Wang Yu Gary Ng Director 24 Jun 2025
Wing Tak Wendy YU Director 24 Jun 2025
Steven D. Rubin Director 24 Jun 2025
Hamed Shahbazi Director 24 Jun 2025

Recent Insider Transactions by Companies or Individuals for Niagen Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.